Jean George
CIK 1291804 · last filed 2024-02-16
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$489.1K
Companies
8
Total Filings
43
Lifetime Open-Market Net
-$34.38M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Cyteir Therapeutics, Inc. (CYT) Delisted | Director | 2,458,415 | $3.02 | $7.42M | $0 | 4 | 2024-02-16 |
| CALA | Director | 1,810,082 | $0.00 | $543 | $3.00M | 8 | 2021-06-14 |
| ALXO | 10%+ Owner | 309,222 | $1.58 | $488.6K | $68.40M | 1 | 2020-07-22 |
| ACCELERON PHARMA INC (XLRN) Delisted | Director | 5,127 | $178.75 | $916.5K | -$57.46M | 15 | 2020-01-24 |
| Astria Therapeutics, Inc. (CATB) Delisted | Director | 90,764 | $8.54 | $775.1K | $3.11M | 4 | 2018-06-07 |
| Zeltiq Aesthetics Inc (ZLTQ) Delisted | Director | 5,786 | — | — | -$51.43M | 9 | 2015-07-23 |
| PORTOLA PHARMACEUTICALS INC (PTLA) Delisted | Director | 27,939 | — | — | $0 | 1 | 2013-05-30 |
| CORNERSTONE THERAPEUTICS INC (CRTX) Delisted | Director | — | $1.95 | — | $0 | 1 | 2007-05-03 |
Recent Filings · Page 4 of 5
43 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-01-09 | ACCELERON PHARMA INC (XLRN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-12-10 | ACCELERON PHARMA INC (XLRN) Delisted | Sell (S) | −97,407 | -$4.37M | EDGAR |
| 2014-11-04 | Zeltiq Aesthetics Inc (ZLTQ) Delisted | Mixed | — | -$335.9K | EDGAR |
| 2014-10-09 | CALA | Mixed | +2,110,082 | $3.00M | EDGAR |
| 2014-07-31 | Zeltiq Aesthetics Inc (ZLTQ) Delisted | Sell (S) | −29,157 | -$585.8K | EDGAR |
| 2014-01-22 | Zeltiq Aesthetics Inc (ZLTQ) Delisted | Mixed | −2,000,000 | -$702.9K | EDGAR |
| 2013-12-09 | ACCELERON PHARMA INC (XLRN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2013-11-18 | Zeltiq Aesthetics Inc (ZLTQ) Delisted | Sell (S) | −4,025,000 | -$49.19M | EDGAR |
| 2013-09-26 | ACCELERON PHARMA INC (XLRN) Delisted | Mixed | +2,504,051 | $0 | EDGAR |
| 2013-06-20 | Zeltiq Aesthetics Inc (ZLTQ) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.